Carolin C. Hack

Erlangen, BY, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

Breast MRI With Abbreviated Reading Protocol as Additional Evaluation Tool for Suspicious Microcalcifications in a Screening Cohort: Diagnostic Performance and Interreader Agreement.

Breast MRI With Abbreviated Reading Protocol as Additional Evaluation Tool for Suspicious Microcalcifications in a Screening Cohort: Diagnostic Performance and Interreader Agreement.

Journal: Anticancer research
Published: June 01, 2026

Breast cancer prevention in patients with gBRCA-mutated ovarian cancer.

Breast cancer prevention in patients with gBRCA-mutated ovarian cancer.

Journal: Journal of cancer research and clinical oncology
Published: May 05, 2026

Breast cancer risk genes affecting individual radiosensitivity.

Breast cancer risk genes affecting individual radiosensitivity.

Journal: Scientific reports
Published: March 10, 2026

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.

PARP inhibition with olaparib and talazoparib for HER2-negative advanced breast cancer-Results from the prospective PRAEGNANT registry.

Journal: NPJ breast cancer
Published: November 29, 2025

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.

Alpelisib and Fulvestrant in PIK3CA-mutated hormone receptor-positive HER2-negative advanced breast cancer included in the German PRAEGNANT trial.

Journal: Breast cancer research and treatment
Published: October 24, 2025

Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center.

Quality of care before and after initial certification at a German certified hereditary breast and ovarian cancer center.

Journal: Journal of cancer research and clinical oncology
Published: October 01, 2025

Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications.

Genetic tumor syndromes in female cancer: insights into inherited cancer predisposition and clinical implications.

Journal: Archives of gynecology and obstetrics
Published: September 01, 2025

Integration of complementary medicine in uro-oncology

Integration of complementary medicine in uro-oncology

Journal: Urologie (Heidelberg, Germany)
Published: June 11, 2025

Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.

Prognostic impact of the choice of chemotherapy after first-line CDK4/6 inhibitor therapy in patients with metastatic hormone receptor-positive, HER2-negative breast cancer.

Journal: European journal of cancer (Oxford, England : 1990)
Published: June 05, 2025

Cross-sectional study on user requirements for developing a digital patient navigator app.

Cross-sectional study on user requirements for developing a digital patient navigator app.

Journal: Digital health
Published: April 11, 2025

Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer.

Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer.

Journal: Geburtshilfe und Frauenheilkunde
Published: March 16, 2025

Correction: Comparative assessment of breast volume using a smartphone device versus MRI.

Correction: Comparative assessment of breast volume using a smartphone device versus MRI.

Journal: Breast cancer (Tokyo, Japan)
Published: March 02, 2025
Showing 1-12 of 99

Last Updated: 09/26/2026